These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

574 related items for PubMed ID: 22948137

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Relationship between pretreatment bone resorption and vertebral fracture incidence in postmenopausal osteoporotic women treated with risedronate.
    Seibel MJ, Naganathan V, Barton I, Grauer A.
    J Bone Miner Res; 2004 Feb; 19(2):323-9. PubMed ID: 14969403
    [Abstract] [Full Text] [Related]

  • 25. Osteodensitometry in healthy postmenopausal women.
    Prescrire Int; 2008 Apr; 17(94):68-72. PubMed ID: 18536138
    [Abstract] [Full Text] [Related]

  • 26. Cost-effectiveness of alendronate for the treatment of osteopenic postmenopausal women in Japan.
    Moriwaki K, Komaba H, Noto S, Yanagisawa S, Takiguchi T, Inoue H, Toujo T, Fukagawa M, Takahashi HE.
    J Bone Miner Res; 2013 Feb; 28(2):395-403. PubMed ID: 22991163
    [Abstract] [Full Text] [Related]

  • 27. Timing and risk factors for clinical fractures among postmenopausal women: a 5-year prospective study.
    van Geel AC, Geusens PP, Nagtzaam IF, Schreurs CM, van der Voort DJ, Rinkens PE, Kester AD, Dinant GJ.
    BMC Med; 2006 Oct 09; 4():24. PubMed ID: 17029622
    [Abstract] [Full Text] [Related]

  • 28. Independent predictors of all osteoporosis-related fractures among healthy Saudi postmenopausal women: the CEOR Study.
    Rouzi AA, Al-Sibiani SA, Al-Senani NS, Radaddi RM, Ardawi MS.
    Bone; 2012 Mar 09; 50(3):713-22. PubMed ID: 22178778
    [Abstract] [Full Text] [Related]

  • 29. Evaluation of the FRAX and Garvan fracture risk calculators in older women.
    Bolland MJ, Siu AT, Mason BH, Horne AM, Ames RW, Grey AB, Gamble GD, Reid IR.
    J Bone Miner Res; 2011 Feb 09; 26(2):420-7. PubMed ID: 20721930
    [Abstract] [Full Text] [Related]

  • 30. The Fracture Risk Assessment Tool (FRAX®): applications in clinical practice.
    Watts NB.
    J Womens Health (Larchmt); 2011 Apr 09; 20(4):525-31. PubMed ID: 21438699
    [Abstract] [Full Text] [Related]

  • 31. Less strict intervention thresholds for the FRAX and TBS-adjusted FRAX predict clinical fractures in osteopenic postmenopausal women with no prior fractures.
    Kužma M, Hans D, Koller T, Némethová E, Jackuliak P, Killinger Z, Resch H, Payer J.
    J Bone Miner Metab; 2018 Sep 09; 36(5):580-588. PubMed ID: 28884422
    [Abstract] [Full Text] [Related]

  • 32. Prevalence of osteoporosis, osteopenia, and vertebral fractures in long-term renal transplant recipients.
    Marcén R, Caballero C, Uriol O, Fernández A, Villafruela JJ, Pascual J, Martins J, Rodriguez N, Burgos FJ, Ortuño J.
    Transplant Proc; 2007 Sep 09; 39(7):2256-8. PubMed ID: 17889156
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. A study of the value of trabecular bone score in fracture risk assessment of postmenopausal women.
    Mirzaei A, Jahed SA, Nojomi M, Rajaei A, Zabihiyeganeh M.
    Taiwan J Obstet Gynecol; 2018 Jun 09; 57(3):389-393. PubMed ID: 29880171
    [Abstract] [Full Text] [Related]

  • 35. Calcaneus ultrasonometry and dual-energy X-ray absorptiometry for the evaluation of vertebral fracture risk.
    Frediani B, Acciai C, Falsetti P, Baldi F, Filippou G, Siagkri C, Spreafico A, Galeazzi M, Marcolongo R.
    Calcif Tissue Int; 2006 Oct 09; 79(4):223-9. PubMed ID: 16969597
    [Abstract] [Full Text] [Related]

  • 36. Comparison of trabecular bone score and hip structural analysis with FRAX® in postmenopausal women with type 2 diabetes mellitus.
    Bonaccorsi G, Fila E, Messina C, Maietti E, Ulivieri FM, Caudarella R, Greco P, Guglielmi G.
    Aging Clin Exp Res; 2017 Oct 09; 29(5):951-957. PubMed ID: 27722900
    [Abstract] [Full Text] [Related]

  • 37. Fracture risk among treatment-naïve postmenopausal women with osteopenia in Greece: results from the "ACROSS" study.
    Anastasilakis AD, Makras P.
    Arch Osteoporos; 2020 Oct 16; 15(1):163. PubMed ID: 33067646
    [Abstract] [Full Text] [Related]

  • 38. Correlation between osteoporotic fracture risk in Brazilian postmenopausal women calculated using the FRAX with and without the inclusion of bone densitometry data.
    Bastos-Silva Y, Aguiar LB, Pinto-Neto AM, Baccaro LF, Costa-Paiva L.
    Arch Osteoporos; 2016 Oct 16; 11():16. PubMed ID: 27067597
    [Abstract] [Full Text] [Related]

  • 39. Fracture Risk Assessment Tool (FRAX®) Results Calculated With and Without Bone Mineral Density Values for the Evaluation of Fracture Risk in Postmenopausal Women With Osteopenia.
    Imerci A, Yalın Kılınç C, Aydogan NH, Karalezli MN, Savran A.
    J Clin Densitom; 2018 Oct 16; 21(4):464-471. PubMed ID: 28781230
    [Abstract] [Full Text] [Related]

  • 40. Fracture risk assessment in postmenopausal women with diabetes: comparison between DeFRA and FRAX tools.
    Bonaccorsi G, Messina C, Cervellati C, Maietti E, Medini M, Rossini M, Massari L, Greco P.
    Gynecol Endocrinol; 2018 May 16; 34(5):404-408. PubMed ID: 29172781
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 29.